ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 490 out of 6969

$1.07M Total Retail Price of All Prescriptions

Rank: 123 out of 6969

304 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 304 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,857 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

59% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$112 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CRESTOR 574 567 1 39
ACTONEL 336 328 2 115
EXFORGE 301 289 3 190
LIDODERM 298 269 4 75
BYSTOLIC 289 282 5 155
BENICAR 265 259 6 107
AMLODIPINE BESYLATE 260 223 7 4
METFORMIN HCL ER 257 235 8 82
JANUVIA 256 245 9 41
LOVAZA 249 235 10 77
ATORVASTATIN CALCIUM 247 234 11 11
METOPROLOL SUCCINATE 232 212 12 22
CELEBREX 211 195 13 67
LOSARTAN POTASSIUM 210 189 14 12
ATELVIA 173 167 15 111
AZOR 160 156 16 233
TAMSULOSIN HCL 157 156 17 23
WELCHOL 153 148 18 235
VOLTAREN 139 129 19 105
DIOVAN 137 130 20 26
ZOLPIDEM TARTRATE 137 118 20 16
SPIRIVA 128 127 22 66
TRIAMCINOLONE ACETONIDE 121 117 23 55
TRILIPIX 120 120 24 175
GABAPENTIN 112 103 25 17
OMEPRAZOLE 107 98 26 6
ISOSORBIDE MONONITRATE ER 101 101 27 81
FLUTICASONE PROPIONATE 97 93 28 24
BISOPROLOL-HYDROCHLOROTHIAZIDE 88 88 29 258
PLAVIX 88 84 29 68
LOVASTATIN 85 65 31 15
ETODOLAC 84 79 32 219
ZENPEP 82 67 33 283
ALENDRONATE SODIUM 82 73 33 14
AVODART 81 57 35 108
LOPERAMIDE 78 75 36 321
IBUPROFEN 71 58 37 29
CLOPIDOGREL 70 66 38 48
SURE COMFORT ALCOHOL 70 66 38 269
TRADJENTA 66 62 40 325
NAPROXEN 60 56 41 62
LIPITOR 59 58 42 89
MECLIZINE HCL 55 51 43 100
ZOSTAVAX 52 39 44 79
ULORIC 52 52 44 243
CROMOLYN SODIUM 51 50 46 320
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.